The PHE Will End May 11

Published in Government Relations on January 31, 2023

President Biden has announced that the COVID-19 Public Health Emergency (PHE) will officially end on May 11, 2023. This PHE was initially announced in early 2020 and has been renewed in multiple 90-day increments since then, most recently on Jan. 11.  

What Ending the PHE Means for DMEPOS Suppliers 

There are several provisions which impact the DMEPOS industry tied to the duration of the PHE. With the official ending of the PHE now in sight, most of those provisions and waivers that are still in place will end on May 11, 2023. Those waivers impacted signature/documentation requirements, reimbursement methodology, and modified medical policies (LCD), etc. A full list of all waivers can be found here, and the waivers specific to DMEPOS suppliers can be found here.  

For those beneficiaries that received equipment with a waiver, we are still awaiting direction from CMS. When we met with CMS in the past to share concerns regarding patients in the post-PHE transition, CMS representatives indicated they would provide ample time with instruction. Once we receive this direction from CMS and the local DME MACs, we will provide the information to the supplier community.  

In the meantime, start running reports in your billing software looking for those claims with the CR modifier and claim narrative (COVID-19). Know the status of those beneficiaries and claims in preparation for any instruction we shall receive. 

Regarding the 75/25 blended reimbursement rates for providers serving Medicare beneficiaries in non-rural, non-competitive bid areas, these rates will not expire with the PHE, as first intended. Introduced and implemented by CMS after the passage of the CARES Act in March 2020, these increased reimbursement rates were initially tied to the PHE, meaning they would go away as soon as the PHE was officially ended. However, the Omnibus bill passed at the end of 2022 ensured that those 75/25 blended rates would remain in place through the end of 2023 if the PHE ended during 2023.  

That means that reimbursement for DMEPOS providers will be as follows: 

  • Providers serving Medicare beneficiaries located within CBAs will continue to receive the CBA rates (the higher blended rates were never applied in these areas). 
  • Providers serving Medicare beneficiaries located in non-rural, non-competitive bid areas will receive the 75/25 blended rates for dates of service up to and including Dec. 31, 2023. On Jan. 1, 2024, those blended rates will end, and reimbursement will revert to rates similar to what was in place prior to the PHE. Those pre-pandemic rates, however, will be adjusted based on the CPI-U increases for 2022 (between 5.1 and 5.4%) and 2023 (between 6.4 and 9.1%). 
  • Providers serving Medicare beneficiaries in rural areas will continue to receive the 50/50 blended rates indefinitely. These rural rates have been in place since 2018, prior to the PHE declaration, and will remain in effect until further rulemaking changes them. They will not end when the PHE does, nor will they end on Dec. 31, 2023, with the 75/25 blended rates. 

As always, the experts in VGM Government Relations will continue to monitor the changes and updates and communicate additional details as needed. Feel free to contact us with any questions related to this topic.  


TAGS

  1. phe
  2. vgm
  3. vgm government

From Our Experts

Arkansas Introduces a Bill to Exempt Breast Pump Supplies From Sales Taxes thumbnail Arkansas Introduces a Bill to Exempt Breast Pump Supplies From Sales Taxes In Arkansas, mothers who pump breast milk are required to pay sales tax when they buy their equipment. Breast pumps are basic necessities for breastfeeding mothers, and taxing pumps limits access to breastfeeding by making the product more expensive. Changes to the New Oxygen Equipment Medical Policy thumbnail Changes to the New Oxygen Equipment Medical Policy For those providers who supply home oxygen equipment, it's vital to be familiar with the changes that are being implemented Jan. 1, 2023. California is Moving Forward with Bill to Remove Tax on Breast Pump Equipment thumbnail California is Moving Forward with Bill to Remove Tax on Breast Pump Equipment In California, mothers who pump breast milk are required to pay sales tax when they buy their equipment. Meanwhile, infant formula is generally exempted from taxation. Breast pumps are basic necessities for breastfeeding mothers, and taxing pumps limits access to breastfeeding by making the product more expensive. Time is Almost up to Send in Comments over Medicare Coverage of Seat Elevation Systems thumbnail Time is Almost up to Send in Comments over Medicare Coverage of Seat Elevation Systems The comment period is set to go for ONE MORE WEEK! All comments must be in by the end of the day Friday, March 17. CMS Opens Comment Period for Power Seat Elevation Coverage thumbnail CMS Opens Comment Period for Power Seat Elevation Coverage Last week, CMS announced the opening of a comment period relating to the request for Medicare coverage of power seat elevation systems used with complex power wheelchairs. Ronda Vlog: Additional Information Regarding the New Oxygen Policy thumbnail Ronda Vlog: Additional Information Regarding the New Oxygen Policy Listen below Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement talks through questions and additional information, and updates on the new oxygen policy. Tom Powers Visit Washington D.C. thumbnail Tom Powers Visit Washington D.C. With the start of the 118th Congress and all members of Congress returning to D.C., VGM Government Relations' Tom Powers headed to Capitol Hill. OIG Recommends 'High/Low Reward' Strategy on Intermittent Catheters thumbnail OIG Recommends 'High/Low Reward' Strategy on Intermittent Catheters In this episode of Industry Matters, Alan Morris, Director of Research and Strategy for VGM Government Relations, and John Gallagher, VP of VGM Government Relations, talk with Brian Leitten from Leitten Consulting, about a new study, "OIG Recommends 'High Risk/Low Reward' Strategy on Intermittent Catheters." The study looks at concerns and costs associated with reducing access to urinary catheters.